chr2-99361565-T-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM1BP4_ModerateBS2
The ENST00000289371.11(EIF5B):āc.664T>Gā(p.Ser222Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0001 in 1,612,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000289371.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EIF5B | NM_015904.4 | c.664T>G | p.Ser222Ala | missense_variant | 4/24 | ENST00000289371.11 | NP_056988.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EIF5B | ENST00000289371.11 | c.664T>G | p.Ser222Ala | missense_variant | 4/24 | 1 | NM_015904.4 | ENSP00000289371 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152020Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000974 AC: 24AN: 246380Hom.: 0 AF XY: 0.0000673 AC XY: 9AN XY: 133744
GnomAD4 exome AF: 0.000106 AC: 155AN: 1460010Hom.: 0 Cov.: 31 AF XY: 0.0000964 AC XY: 70AN XY: 726254
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152020Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74268
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2023 | The c.664T>G (p.S222A) alteration is located in exon 4 (coding exon 4) of the EIF5B gene. This alteration results from a T to G substitution at nucleotide position 664, causing the serine (S) at amino acid position 222 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at